Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2014

Aug 26, 2014

34595_dirs_2014-08-26_83bea04b-2681-4446-a136-b637e28609db.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2014-08-25

Reporting Person: Devine John P (VP--Toxicology)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-25 Common Stock M 2500 $1.01 Acquired 2500 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-25 Option to Purchase Common Shares $1.01 M 2500 Disposed 2020-08-15 Common Shares (2500) Direct

Footnotes

F1: The option, representing the right to purchase a total of 10,000 shares, vests and becomes exercisable in four equal annual installments beginning on August 16, 2012.